InvestorsHub Logo
Followers 145
Posts 27561
Boards Moderated 3
Alias Born 02/07/2004

Re: midastouch017 post# 1265

Tuesday, 05/03/2016 11:15:52 AM

Tuesday, May 03, 2016 11:15:52 AM

Post# of 1367

if approved, is likely to be widely prescribed. In the future, new Kitov combination drugs would follow KIT-302's pattern of low development risk and efficient regulatory pathways, returning a quicker than usual return on investment.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.